O-1918
O-1918 is a synthetic compound that was originally identified in the early 2000s. It is often associated with the cannabinoid system due to its ability to act as an antagonist for the GPR18 receptor, which is a target of interest in the field of pharmacology.
History[edit | edit source]
O-1918 was first identified in the early 2000s. It was initially thought to be an antagonist for the CB1 receptor and CB2 receptor, which are the primary targets of the cannabinoid system. However, subsequent research has shown that O-1918 does not have significant activity at these receptors. Instead, it has been found to act as an antagonist for the GPR18 receptor.
Pharmacology[edit | edit source]
The primary target of O-1918 is the GPR18 receptor. This receptor is a member of the G protein-coupled receptor family and is expressed in various tissues throughout the body, including the central nervous system and immune system. The exact role of GPR18 is still not fully understood, but it is thought to be involved in a variety of physiological processes, including inflammation, pain perception, and immune response.
O-1918 acts as an antagonist for the GPR18 receptor, meaning that it blocks the receptor's activity. This can potentially be used to modulate the receptor's effects, although the exact therapeutic potential of O-1918 is still under investigation.
Research and Potential Therapeutic Uses[edit | edit source]
Research into O-1918 and the GPR18 receptor is still in its early stages. However, due to the wide expression of GPR18 and its involvement in various physiological processes, there is significant interest in the potential therapeutic uses of O-1918.
Some potential areas of interest include the treatment of chronic pain, inflammatory diseases, and neurodegenerative diseases. However, more research is needed to fully understand the potential benefits and risks of O-1918.
See Also[edit | edit source]
O-1918 Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD